Theivanthiran, B.; Haykal, T.; Cao, L.; Holtzhausen, A.; Plebanek, M.; DeVito, N.C.; Hanks, B.A.
Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis. Cancers 2021, 13, 4753.
https://doi.org/10.3390/cancers13194753
AMA Style
Theivanthiran B, Haykal T, Cao L, Holtzhausen A, Plebanek M, DeVito NC, Hanks BA.
Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis. Cancers. 2021; 13(19):4753.
https://doi.org/10.3390/cancers13194753
Chicago/Turabian Style
Theivanthiran, Balamayooran, Tarek Haykal, Linda Cao, Alisha Holtzhausen, Michael Plebanek, Nicholas C. DeVito, and Brent A. Hanks.
2021. "Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis" Cancers 13, no. 19: 4753.
https://doi.org/10.3390/cancers13194753
APA Style
Theivanthiran, B., Haykal, T., Cao, L., Holtzhausen, A., Plebanek, M., DeVito, N. C., & Hanks, B. A.
(2021). Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis. Cancers, 13(19), 4753.
https://doi.org/10.3390/cancers13194753